Virtu Financial’s Spectrum Pharmaceuticals SPPI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q3
– Sell
-157,908
Closed -$152K – 2202
2023
Q2
$152K Buy
157,908
+93,394
+145% +$92.3K 0.01% 903
2023
Q1
$48K Buy
+64,514
New +$47.1K 0.01% 1108
2022
Q3
– Sell
-61,561
Closed -$48K – 2428
2022
Q2
$48K Buy
+61,561
New +$54.3K ﹤0.01% 1134
2021
Q4
– Sell
-100,269
Closed -$219K – 2338
2021
Q3
$219K Buy
+100,269
New +$274K 0.02% 878
2021
Q1
– Sell
-60,019
Closed -$205K – 2195
2020
Q4
$205K Buy
+60,019
New +$247K 0.02% 848
2018
Q3
– Sell
-10,466
Closed -$219K – 2364
2018
Q2
$219K Sell
10,466
-7,440
-42% -$138K 0.01% 1436
2018
Q1
$288K Buy
+17,906
New +$355K 0.02% 1082

Virtu Financial's SPPI Position: Q3 2023 in Review

Virtu Financial sold out of Spectrum Pharmaceuticals (SPPI) in Q3 2023, closing a stake of 157,908 shares — an estimated $152K sold.

Virtu Financial first reported a position in SPPI in Q1 2018 and held it in 7 quarters. The position peaked at $288K in Q1 2018. 0 funds tracked by Wall St. Rank hold SPPI as of Q3 2023.

  • Virtu Financial reported no remaining Spectrum Pharmaceuticals position as of Q3 2023 after selling out during the quarter.
  • Virtu Financial sold 157,908 Spectrum Pharmaceuticals shares in Q3 2023, an estimated $152K.
  • Virtu Financial first reported a position in Spectrum Pharmaceuticals in Q1 2018 and held it in 7 quarters.
  • Virtu Financial's Spectrum Pharmaceuticals position peaked at $288K in Q1 2018.
  • 0 funds tracked by Wall St. Rank held Spectrum Pharmaceuticals as of Q3 2023.

Based on Virtu Financial's 13F filing for Q3 2023, filed 15 Nov 2023.